Axcella Health Inc. stock is down -0.36% since 30 days ago. The next earnings date is Dec 19, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 December’s closed higher than November.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction of risk of overt hepatic encephalopathy recurrence.